hAd5-Covid-19

N/A

Report date: 2026/05/13 11:17:58

Base Information

Drug NamehAd5-Covid-19
Drug Alias NameCOVID-2019 vaccine ( ImmunityBio/NantKwest)Ad5-Covid-S/N vaccinehAd5-S-Fusion+N-ETSD vaccineE1/E2B/E3-Deleted Adenoviral-COVID-19COVID 2019 vaccine +[12] 
ClassificationVaccines > Development/production technology > Recombinant vector vaccine > Viral vector vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Africa
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmunitybio IncNantkwest Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunitybio Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A